Cancer, as a disease, involves a whole range of uncontrolled and abnormal tissue growth that invades and damages nearby tissues and parts of the body through the blood and lymphatic systems. The disease results from cellular DNA mutations that disrupt cells' normal patterns of growth, division, and death. Such mutations may be inherited, caused by factors in the environment, or caused by random events during replication of DNA within cells. Cancer occurs when normal cellular pathways to regulate apoptosis, or programmed cell death, as well as repair of damaged DNA, fail, ultimately leading to unrestricted division of cells. This uncontrolled proliferation of cells results in the formation of a mass, known simply as a tumor. This is the term given to any aggregated tissue formed by the accumulation of abnormal cells. Tumors are classified as benign or malignant. Benign tumors do not spread anywhere else and are not cancerous, but they are bad because they can push on nearby organs. In contrast, malignant tumors are cancerous, able to invade nearby tissues, and are able to metastasize, that is, spread to distant sites in the body via blood vessels or the lymphatic system.
Mutations in genes, which are mainly oncogenes, tumor suppressor genes and DNA repair genes, are the genetic basis of cancer. The term oncogene refers to genes that, when mutated or over-expressed, promote cell growth and division beyond normal limits. Tumor suppressor genes counter this by acting as brakes, controlling excessive cell proliferation, and playing another role of repairing or eliminating damaged cells. Thus such mutations will lose their regulatory functions. DNA repair genes will in turn correct mistakes made during DNA replication and repair environmental damage. When something goes wrong with these repair mechanisms, more mutations will be present and, thus, the likelihood of getting cancer increases. Cancer has great diversity in the parts of the body it can attack and there are significant differences for classification purposes. Cancer is classified into some major types which include carcinoma, sarcoma, leukemia, lymphoma and CNS cancer according to the tissue or cell type. Carcinoma is the most common and arises from epithelial cells covering surfaces and cavities within organs and glands. These include lung cancer, breast cancer and colorectal cancer. However, sarcomas are those that arise from connective tissues such as bone, cartilage, muscle, or fat. Leukemia is defined as cancer of the blood and bone marrow that produces excessive amounts of abnormal white blood cells. Lymphomas are cancers that affect the lymphatic system organs, including lymph nodes and lymphoid tissues. Tumors arising from the brain and spinal cord are called central nervous system cancers. The cancer development process—carcinogenesis or tumorigenesis—occurs in stages: initiation, promotion, progression, and metastasis. Initially, a genetic mutation in a single cell causes an abnormal behavior. During promotion, cells begin to proliferate selectively and form a premalignant lesion. The term progression is defined as further mutations that form a fully malignant tumor capable of rapid growth and invasion. Ultimately, the cancer progresses to the metastatic stage. In this stage, cancer cells separated from the original tumor invade nearby tissues and from there reach distant organs and form secondary tumors. The hallmarks of cancer are the essential characteristics that distinguish cancer cells from normal cells as purportedly determined by scientists. These include maintaining proliferative signaling, avoiding growth suppressors, resisting cell death, enabling replicative immortality, angiogenesis (the supply of new blood vessels through which nutrients can be delivered to the tumor) and inducing invasion and metastasis. Doing is involved. Other distinguishing features are reprogramming of cellular metabolism to become efficient and suitable for rapid growth, escape from immune destruction, and display of genomic instability, leading to increased mutation rates. As a result, genetic, environmental, and lifestyle factors can be broadly classified into different categories. In some cancers, genetic predisposition may be an inherited mutation that increases individual risk. Environmental factors include exposure to carcinogenic substances such as tobacco smoke, ultraviolet radiation, ionizing radiation, asbestos, and industrial chemicals. Poor diet, physical inactivity, obesity and alcohol also increase cancer risk due to lifestyle effects. Human papillomavirus (HPV), hepatitis B and C viruses or even Epstein-Barr virus, as well as particular infections caused by bacteria such as Helicobacter pylori are associated with specific types of cancer. Symptoms of cancer depend greatly on the type, location, and stage of the disease. Some of the most common signs and symptoms include: unexplained weight loss; chronic fatigue; Pain; Changes in the appearance of the skin, such as paleness, darkening, or redness; unusual bleeding or bruising; and lumps or swelling that develop over time. However, sometimes there are no symptoms in the early stages of cancer, but it may be detected later through routine checkups or incidental findings.
Diagnosis of cancer usually involves clinical examination, imaging studies (such as X-rays, CT scans, and MRI), laboratory tests (including blood tests for tumor markers), and biopsies to rule out any malignant changes. Are subject to microscopic examination. However, advances in molecular diagnostics, including genetic and genomic testing, provide much refined specificity in defining cancer at the molecular level and guiding treatment decisions. Generally, treatment for cancer depends on many factors, especially the type, stage, and many individual issues. The most commonly used treatment modalities in the management of cancer patients include surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and hormonal therapy. Surgical therapy is to remove the tumor along with surrounding tissues to prevent local spread. In contrast, chemotherapy works by using fast-acting drugs that kill rapidly dividing cells or stop their spread. Chemotherapy kills cancer cells, but normal cells are harmed because of the high division in these cells causing side effects.
Radiotherapy: This means using high-energy radiation to damage or destroy cancer cells or shrink tumors. Immunotherapy is the recognition of a malignant disease by the immune system so that these cells can attack and destroy it. In contrast, targeted therapy uses drugs that interfere with molecular pathways involved in cancer-related processes. Hormonal therapy is especially recommended in cancers such as breast and prostate. Major breakthroughs in personalized medicine have revolutionized cancer treatment, allowing a tailored therapeutic approach in the context of the genetic and molecular profile of each patient's tumor. Such personalized therapy may prove to be more efficacious with less toxicity. Additionally, cancer prevention and early detection measures are important in reducing the burden of cancer—including lifestyle changes, vaccines (e.g., HPV vaccine), and reduced exposure to known carcinogens—and including mammograms, Pap smears, and colonoscopies. Screening programs, such as these, are meant to identify cancer at an early stage when it is more amenable to treatment. The prognosis of cancer varies widely depending on its type, stage, and biological behavior, as well as the availability and effectiveness of treatments. Early-stage cancers generally have better outcomes, while those diagnosed with more advanced spread present a more difficult treatment challenge. An understanding of cancer biology forms the basis of most ongoing research in oncology. An understanding of cancer biology forms the basis of most ongoing research in oncology. This will simplify the development of new treatment methods and treatments. Cancer, overall, is the leading cause of death globally and a major public health challenge. Yet, even though this is only part of the picture, advances in detection, treatment, and prevention have also resulted in declining mortality rates for many cancers. Investing in public awareness, access to healthcare and research for the global fight against cancer will make a difference in fighting cancer and improving health outcomes for those affected.
